| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abitylguanide: Adenovirus reproduction inhibitor efficient in the treatment of epidemic keratoconjunctivitis (EKC)
|
|
|
1992
|
17 |
S1 |
p. 143-
1 p.
|
artikel
|
| 2 |
Accurate quantitation of HIV DNA and RNA sequences using quantitative competitive polymerase chain reaction (QC-PCR)
|
|
|
1992
|
17 |
S1 |
p. 64-
1 p.
|
artikel
|
| 3 |
A comparison of the compound binding sites on human rhinovirus-14 and -1a; examination of rigid analogues of win 54954
|
|
|
1992
|
17 |
S1 |
p. 89-
1 p.
|
artikel
|
| 4 |
A comparison of the in vitro antiviral potency of 2 thio 6 azauridine with ribavirm and selenazofurin against selected positive- and negative-stranded RNA viruses
|
|
|
1992
|
17 |
S1 |
p. 136-
1 p.
|
artikel
|
| 5 |
A convenient method for the synthesis of 2', 3'-dideoxynucleosides
|
|
|
1992
|
17 |
S1 |
p. 57-
1 p.
|
artikel
|
| 6 |
Activity of penciclovir and acyclovir in DBA/2 mice infected intraperitoneally with HSV-1 (SC16)
|
|
|
1992
|
17 |
S1 |
p. 108-
1 p.
|
artikel
|
| 7 |
Acyclic nucleoside phosphonate analogues, markedly enhance natural killer activity in mice
|
|
|
1992
|
17 |
S1 |
p. 86-
1 p.
|
artikel
|
| 8 |
Adenovirus type 5 replication is inhibited by S-HPMPC in the NZ rabbit ocular model
|
|
|
1992
|
17 |
S1 |
p. 158-
1 p.
|
artikel
|
| 9 |
A flow cytometric analysis of the effects of ganciclovir on the expression of cytomegalovirus (CMV) immediate early antigen in peripheral blood mononuclear cells (PBMC) obtained from patients suspected of CMV related disease
|
|
|
1992
|
17 |
S1 |
p. 120-
1 p.
|
artikel
|
| 10 |
Amino acid esters of acyclovir as oral prodrugs
|
|
|
1992
|
17 |
S1 |
p. 118-
1 p.
|
artikel
|
| 11 |
Anticarbohydrate monoclonal antibodies inhibit flavi- and bunyaviruses: Molecular aspects
|
|
|
1992
|
17 |
S1 |
p. 93-
1 p.
|
artikel
|
| 12 |
Anti-herpesvirus activity of a xylomannan isolated from the red seaweed nothogenia fastigiata
|
|
|
1992
|
17 |
S1 |
p. 99-
1 p.
|
artikel
|
| 13 |
Anti-HIV activity of 5-hydroxymethyldeoxyuridine in vitro and in vivo
|
|
|
1992
|
17 |
S1 |
p. 76-
1 p.
|
artikel
|
| 14 |
Anti-HIV-1 activity of rev and gag phosphorothioate oligo-deoxynucleotides in chronically and acutely infected cells
|
|
|
1992
|
17 |
S1 |
p. 63-
1 p.
|
artikel
|
| 15 |
Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([tyr5,12,lys7]polyphemusin II) — A possible inhibitor for virus-cell Fusion
|
|
|
1992
|
17 |
S1 |
p. 71-
1 p.
|
artikel
|
| 16 |
Anti-SV40 and anti-HIV-1 tat activity of natural and modified oligonucleotides
|
|
|
1992
|
17 |
S1 |
p. 84-
1 p.
|
artikel
|
| 17 |
Antiviral activity of a series of cobalt containing complexes against herpesvirus infection in vitro and in vivo
|
|
|
1992
|
17 |
S1 |
p. 114-
1 p.
|
artikel
|
| 18 |
Antiviral activity of marine plants from india
|
|
|
1992
|
17 |
S1 |
p. 154-
1 p.
|
artikel
|
| 19 |
Antiviral activity of 9-{2-(phosphonomethoxy)ethoxy}purines against HIV, FIV and visna virus
|
|
|
1992
|
17 |
S1 |
p. 59-
1 p.
|
artikel
|
| 20 |
Antiviral activity of piracetam, Y.M. centifanto, tulane university school of medicine, new orleans, louisiana (USA)
|
|
|
1992
|
17 |
S1 |
p. 114-
1 p.
|
artikel
|
| 21 |
Antiviral activity of protease inhibitors on the replications of orthoand paramyxoviruses
|
|
|
1992
|
17 |
S1 |
p. 137-
1 p.
|
artikel
|
| 22 |
Antiviral and immunomodulating activities of polysacchrides extracted from medicinal fungi and herbs
|
|
|
1992
|
17 |
S1 |
p. 141-
1 p.
|
artikel
|
| 23 |
Antiviral drug screening against hepatitis A virus and the effects of selected potential anti-HAV agents
|
|
|
1992
|
17 |
S1 |
p. 145-
1 p.
|
artikel
|
| 24 |
Antiviral effect of interferon inducers (florenons) on exoerimental bunyavirus infections in the soviet union
|
|
|
1992
|
17 |
S1 |
p. 153-
1 p.
|
artikel
|
| 25 |
Antiviral effect of the combination - yeast enzyme complex and rimantadin
|
|
|
1992
|
17 |
S1 |
p. 140-
1 p.
|
artikel
|
| 26 |
Antiviral efficacy of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) upon oral administration to moloney murine sarcoma virus (MSV)-infected mice
|
|
|
1992
|
17 |
S1 |
p. 76-
1 p.
|
artikel
|
| 27 |
Antiviral phosphate prodrugs. A.Glazier, drug innovation and design Inc., Newton, Mass.
|
|
|
1992
|
17 |
S1 |
p. 77-
1 p.
|
artikel
|
| 28 |
Antiviral strategies in chronic hepatitis B virus infection: Inhibition of duck hepatitis B virus replication in vitro by pyrimidine Analogs
|
|
|
1992
|
17 |
S1 |
p. 146-
1 p.
|
artikel
|
| 29 |
A phase I/IIA study of a human monoclonal anti-cytomegalovirus antibody in patients with AIDS
|
|
|
1992
|
17 |
S1 |
p. 111-
1 p.
|
artikel
|
| 30 |
A randomized comparative trial of high vs. standard dose oral acyclovir on first episode genital herpes infections
|
|
|
1992
|
17 |
S1 |
p. 126-
1 p.
|
artikel
|
| 31 |
A rapid, simple and sensitive HPLC-system for simultaneous analysis of AZT and its mono-, di- and triphosphate derivatives following cellular delivery with neoglycoproteins
|
|
|
1992
|
17 |
S1 |
p. 78-
1 p.
|
artikel
|
| 32 |
A rational approach to the development of antiviral combined chemotherapy by reduction in nucleoside triphosphates levels
|
|
|
1992
|
17 |
S1 |
p. 108-
1 p.
|
artikel
|
| 33 |
Are eukaryotic topoisomerases potential targets for antiviral therapy?
|
|
|
1992
|
17 |
S1 |
p. 155-
1 p.
|
artikel
|
| 34 |
Aryl-α-D-galactosaminides inhibit the ability of rotavirus to bind to and to infect susceptible cells
|
|
|
1992
|
17 |
S1 |
p. 144-
1 p.
|
artikel
|
| 35 |
Assessment of a selective inhibitor of HSV thymidine kinase (TK) as therapy for experimental recurrent genital herpes
|
|
|
1992
|
17 |
S1 |
p. 112-
1 p.
|
artikel
|
| 36 |
A TAT inhibitor (ro 24-7429): The single-dose study in humans
|
|
|
1992
|
17 |
S1 |
p. 85-
1 p.
|
artikel
|
| 37 |
A two day cytoprotection and cytotoxicity assay for rapid anti-HIV drug screening
|
|
|
1992
|
17 |
S1 |
p. 158-
1 p.
|
artikel
|
| 38 |
Author index
|
|
|
1992
|
17 |
S1 |
p. 160-162
3 p.
|
artikel
|
| 39 |
AZT is not synergistic with either ddI, ddC, or carbovir at their proposed site of action, the reverse transcriptase
|
|
|
1992
|
17 |
S1 |
p. 46-
1 p.
|
artikel
|
| 40 |
Benzimidazole ribonucleosides: A new class of antivirals with potent and selective activity against human cytomegalovirus
|
|
|
1992
|
17 |
S1 |
p. 49-
1 p.
|
artikel
|
| 41 |
Benzimidazole ribonucleosides: Antiviral activity and cytotoxicity of combinations of TCRB with ganciclovir, acyclovir, and zidovudine
|
|
|
1992
|
17 |
S1 |
p. 101-
1 p.
|
artikel
|
| 42 |
Benzimidazole ribonucleosides: Cytotoxicity of TCRB and BDCRB to human cells
|
|
|
1992
|
17 |
S1 |
p. 100-
1 p.
|
artikel
|
| 43 |
Benzimidazole ribonucleosides: Design, synthesis and antiviral evaluation of some TCRB analogs
|
|
|
1992
|
17 |
S1 |
p. 100-
1 p.
|
artikel
|
| 44 |
Benzimidazole ribonucleosides: Design, synthesis, and evaluation of 2-chloro-5,6-diiodo-1-(β-D-ribofuranosyl)benzimidazole, an analog of TCRB
|
|
|
1992
|
17 |
S1 |
p. 99-
1 p.
|
artikel
|
| 45 |
Benzimidazole ribonucleosides: In vitro immune function effects of TCRB
|
|
|
1992
|
17 |
S1 |
p. 101-
1 p.
|
artikel
|
| 46 |
Benzimidazole ribonucleosides: Mode of action of TCRB in HCMV-infected cells
|
|
|
1992
|
17 |
S1 |
p. 102-
1 p.
|
artikel
|
| 47 |
Biochemical characterization of HIV-1 reverse transcriptases with mutations associated with DDI resistance and collateral AZT sensitivity
|
|
|
1992
|
17 |
S1 |
p. 47-
1 p.
|
artikel
|
| 48 |
Biochemical defects in the 2-5A synthetase/RNase L antiviral pathway in chronic fatigue syndrome (CFS)
|
|
|
1992
|
17 |
S1 |
p. 159-
1 p.
|
artikel
|
| 49 |
Blockade of function and expression of erythropoietin-receptor (Ep-R) by zidovudine (AZT)
|
|
|
1992
|
17 |
S1 |
p. 88-
1 p.
|
artikel
|
| 50 |
Bone marrow stimulatory cytokines modulate the anti-HIV activity of nucleoside analogues in cultures of monocyte/macrophages
|
|
|
1992
|
17 |
S1 |
p. 85-
1 p.
|
artikel
|
| 51 |
BRL 44385: Selective anti-herpesvirus activity and mode of action
|
|
|
1992
|
17 |
S1 |
p. 95-
1 p.
|
artikel
|
| 52 |
Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses
|
|
|
1992
|
17 |
S1 |
p. 65-
1 p.
|
artikel
|
| 53 |
Cell membranes, cell fusion and phospholipids: New targets and novel inhibitors of HIV-1
|
|
|
1992
|
17 |
S1 |
p. 69-
1 p.
|
artikel
|
| 54 |
Cellular and humoral factors associated with polyriboinosinic-polyribocytidylic acid (poly I:C) induced resistance to banzi virus encephalitis
|
|
|
1992
|
17 |
S1 |
p. 152-
1 p.
|
artikel
|
| 55 |
Cellular metabolism and enzymatic phosphorylation of (2R,5R)-9-[2,5-dihydro-5-(phosphonomethoxy)-2-furanyl]adenine (D4AMPI), an anti-HIV agent
|
|
|
1992
|
17 |
S1 |
p. 66-
1 p.
|
artikel
|
| 56 |
Characterization of a novel antiviral glycoprotein from human serum
|
|
|
1992
|
17 |
S1 |
p. 153-
1 p.
|
artikel
|
| 57 |
Characterization of phosphorylation of HIV reverse transcriptase
|
|
|
1992
|
17 |
S1 |
p. 83-
1 p.
|
artikel
|
| 58 |
Characterization of the dNTP binding sites on HIV-1 reverse transcriptase using 1H NMR
|
|
|
1992
|
17 |
S1 |
p. 70-
1 p.
|
artikel
|
| 59 |
Clinical applications of in vitro susceptibility testing of HIV-1 to zidovudine (AZT)
|
|
|
1992
|
17 |
S1 |
p. 67-
1 p.
|
artikel
|
| 60 |
Clinical correlates of “in vitro” HIV-1 resistance to zidovudine. results of the multicentre Canadian AZT trial (MCAT)
|
|
|
1992
|
17 |
S1 |
p. 71-
1 p.
|
artikel
|
| 61 |
Combination chemotherapy: Antiviral activity of AZT in combination with other anti-HIV agents
|
|
|
1992
|
17 |
S1 |
p. 61-
1 p.
|
artikel
|
| 62 |
Combinations of AZT and analogs of TIBO act synergistically to inhibit HIV-1 infection in vitro
|
|
|
1992
|
17 |
S1 |
p. 46-
1 p.
|
artikel
|
| 63 |
Combination studies with antiviral compounds to prevent reactivation of latent HIV-1 in OM-10.1 cells
|
|
|
1992
|
17 |
S1 |
p. 62-
1 p.
|
artikel
|
| 64 |
Combined antiviral and antimediator treatment for common colds
|
|
|
1992
|
17 |
S1 |
p. 91-
1 p.
|
artikel
|
| 65 |
Comparative clinical trial of ribavirin and zidovudine in HIV-infected pediatric patients. Mexican experience
|
|
|
1992
|
17 |
S1 |
p. 80-
1 p.
|
artikel
|
| 66 |
Comparative pharmacology of a group of polyoxometalates possessing broad-spectrum antiviral activity
|
|
|
1992
|
17 |
S1 |
p. 78-
1 p.
|
artikel
|
| 67 |
Comparative study of polyamine pools in HCMV-, MCMV-, and GPCMV- infected mammalian cells
|
|
|
1992
|
17 |
S1 |
p. 98-
1 p.
|
artikel
|
| 68 |
Comparison of ganciclovir sensitivity of cytomegalovirus (CMV) isolated from marrow transplant recipients at diagnosis and during treatment of CMV pneumonia
|
|
|
1992
|
17 |
S1 |
p. 104-
1 p.
|
artikel
|
| 69 |
Comparison of rauscher and LP-BM5 MuLV for assessing anti-AIDS drugs In Vitro
|
|
|
1992
|
17 |
S1 |
p. 59-
1 p.
|
artikel
|
| 70 |
Comparison of the in vivo anti-punta toro virus activity of ribavirin, ribavirin triacetate and ribamidine in mice
|
|
|
1992
|
17 |
S1 |
p. 152-
1 p.
|
artikel
|
| 71 |
Conference committees
|
|
|
1992
|
17 |
S1 |
p. 3-
1 p.
|
artikel
|
| 72 |
Controlled trials of nucleoside analogs in chronic carriers of woodchuck hepatitis virus
|
|
|
1992
|
17 |
S1 |
p. 131-
1 p.
|
artikel
|
| 73 |
Cooperativity of a HIV-1 protease inhibitor (SKF 108922) with AZT in acute and chronic HIV-1 infections in vitro
|
|
|
1992
|
17 |
S1 |
p. 47-
1 p.
|
artikel
|
| 74 |
Correction of herpes simplex virus-induced dyslipidemia by antiviral chemical preparations
|
|
|
1992
|
17 |
S1 |
p. 117-
1 p.
|
artikel
|
| 75 |
Development of a human immunodeficiency virus-1 in vitro DNA synthesis system to study reverse transcriptase inhibitors
|
|
|
1992
|
17 |
S1 |
p. 74-
1 p.
|
artikel
|
| 76 |
Development of influenza virus A (H3N2) mutants resistant to mopyridone and study of their M1 protein antigenic structure
|
|
|
1992
|
17 |
S1 |
p. 139-
1 p.
|
artikel
|
| 77 |
Didox and an analog are effective against retrovirus in a murine model (FeLV)
|
|
|
1992
|
17 |
S1 |
p. 77-
1 p.
|
artikel
|
| 78 |
Differential effects of capsid-binding antivirals on the adsorption of rhinoviruses
|
|
|
1992
|
17 |
S1 |
p. 137-
1 p.
|
artikel
|
| 79 |
Differential inhibitory effects of the (S)- and (R)-enantiomers of 9-(3-fluoro-2-phosphonylmethoxypropyl)purine derivatives on retrovirus replication in vitro and in vivo
|
|
|
1992
|
17 |
S1 |
p. 60-
1 p.
|
artikel
|
| 80 |
Effect of CTC-23 on the replication of herpes simplex virus type 1 in human fibroblast cells
|
|
|
1992
|
17 |
S1 |
p. 106-
1 p.
|
artikel
|
| 81 |
Effect of ganciclovir on cytomegalovius disease in renal transplant recipients
|
|
|
1992
|
17 |
S1 |
p. 122-
1 p.
|
artikel
|
| 82 |
Effect of indomethacin on recurrent genital HSV-2 infection in the guinea pig.
|
|
|
1992
|
17 |
S1 |
p. 112-
1 p.
|
artikel
|
| 83 |
Effects of famciclovir in a murine model of encephalitis induced by intranasal inoculation of herpes simplex virus type 1
|
|
|
1992
|
17 |
S1 |
p. 123-
1 p.
|
artikel
|
| 84 |
Efficacy of BMS-180194 against opportunistic cytomegalovirus infection in immunocompromised mice
|
|
|
1992
|
17 |
S1 |
p. 111-
1 p.
|
artikel
|
| 85 |
Efficacy of HPMPC and DHPG in the treatment of murine cytomegalovirus infection in severe combined immune deficiency (SCID) mice
|
|
|
1992
|
17 |
S1 |
p. 110-
1 p.
|
artikel
|
| 86 |
Efficacy of oral WIN 54954 for the prophylaxis of experimental rhinovirus infection
|
|
|
1992
|
17 |
S1 |
p. 92-
1 p.
|
artikel
|
| 87 |
Efficacy of single and combination CTC 23 and trifluorothymidine topical ocular therapy on HSV-1-induced stromal disease in the rabbit
|
|
|
1992
|
17 |
S1 |
p. 115-
1 p.
|
artikel
|
| 88 |
Efficacy of topical preparations containing lithium against herpes simplex virus infections in the mouse
|
|
|
1992
|
17 |
S1 |
p. 115-
1 p.
|
artikel
|
| 89 |
Efficacy of topical treatment with BV-araU cream against cutaneous infection with herpes simplex type 1 in shaved mice
|
|
|
1992
|
17 |
S1 |
p. 116-
1 p.
|
artikel
|
| 90 |
Evaluation of HPMPC therapy for primary and recurrent genital herpes in the guinea pig
|
|
|
1992
|
17 |
S1 |
p. 113-
1 p.
|
artikel
|
| 91 |
Evaluation of oral and topical administration of ribavirin in herpes zoster
|
|
|
1992
|
17 |
S1 |
p. 121-
1 p.
|
artikel
|
| 92 |
Examination of toxicity of DDC, DDI, and D4T as related to their effects on peripheral neurons using a rat PC-12 pheochromocytoma cell line as model
|
|
|
1992
|
17 |
S1 |
p. 87-
1 p.
|
artikel
|
| 93 |
Experimental therapy of immunodeficiency-inducing feline retroviruses with phosphonylmethoxyethyl adenine (PMEA)
|
|
|
1992
|
17 |
S1 |
p. 131-
1 p.
|
artikel
|
| 94 |
Genetic alterations in the gene encoding the major hepatitis B surface antigen: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients
|
|
|
1992
|
17 |
S1 |
p. 147-
1 p.
|
artikel
|
| 95 |
HIV reverse transcriptase: Kinetics of incorporation of nucleotide analogs into heteropolymeric template-primers
|
|
|
1992
|
17 |
S1 |
p. 67-
1 p.
|
artikel
|
| 96 |
HIV-1 specific phenylacetamide derivatives: A novel class of reverse transcriptase inhibitors with potent and selective antiviral activity in vitro
|
|
|
1992
|
17 |
S1 |
p. 45-
1 p.
|
artikel
|
| 97 |
HSV-1 polymerase activity is stimulated in vitro by complex formation with UL42, its accessory protein
|
|
|
1992
|
17 |
S1 |
p. 107-
1 p.
|
artikel
|
| 98 |
Human monoclonal anti cytomegalovirus (CMV) antibody (MSL-109): Enhancement of in vitro foscarnet induced inhibition of CMV replication
|
|
|
1992
|
17 |
S1 |
p. 97-
1 p.
|
artikel
|
| 99 |
4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl purines and pyrimidines, a new class of anti-herpesvirus agents
|
|
|
1992
|
17 |
S1 |
p. 98-
1 p.
|
artikel
|
| 100 |
Identification and characterization of a 47 kDa host protein implicated in the transport of alphaherpesviruses in infected cells
|
|
|
1992
|
17 |
S1 |
p. 151-
1 p.
|
artikel
|
| 101 |
Identification and intracellular location of poliovirus eclipse particles and the influence of chloroquine and R 78206
|
|
|
1992
|
17 |
S1 |
p. 144-
1 p.
|
artikel
|
| 102 |
Identification and Metabolism studies of the active stereo isomer responsible for anti-hepatitis B virus from (±) 2′,3′-dideoxy-3′-thiacytidine
|
|
|
1992
|
17 |
S1 |
p. 130-
1 p.
|
artikel
|
| 103 |
Identification of nucleotide binding site of HIV-1 reverse transcriptase
|
|
|
1992
|
17 |
S1 |
p. 72-
1 p.
|
artikel
|
| 104 |
Immunologic evaluation in PGL patients with ribavirin treatment an open multicentric trial
|
|
|
1992
|
17 |
S1 |
p. 80-
1 p.
|
artikel
|
| 105 |
Immunotherapy of herpetic recurrence and protective immunity to acute HSV infection by interleukin 2-fused glycoprotein D.
|
|
|
1992
|
17 |
S1 |
p. 109-
1 p.
|
artikel
|
| 106 |
Inhibition of hepatitis B virus replication by microalgal extracts
|
|
|
1992
|
17 |
S1 |
p. 130-
1 p.
|
artikel
|
| 107 |
Inhibition of influenza A and B viruses by 2′-fluoronucleosides, mechanism of action on virus replication
|
|
|
1992
|
17 |
S1 |
p. 90-
1 p.
|
artikel
|
| 108 |
Inhibition of influenza A and B viruses reproduction by Di- and tripeptides similar to N-termini of HA2 viral polypeptides
|
|
|
1992
|
17 |
S1 |
p. 140-
1 p.
|
artikel
|
| 109 |
Inhibition of the 3′ to 5′ exonuclease activity of mammalian DNA polymerase δ by 3′-azido-3′-deoxythymidine 5′-monophosphate (AZTMP)
|
|
|
1992
|
17 |
S1 |
p. 87-
1 p.
|
artikel
|
| 110 |
Inhibitory effects of phosphonate nucleotide analogues on human hepatitis B virus DNA synthesis
|
|
|
1992
|
17 |
S1 |
p. 146-
1 p.
|
artikel
|
| 111 |
Interaction of 5-methoxymethyldeoxyuridine triphosphate with DNA polymerases: Effects of the 5-substituent and comparison with the deoxycytidine derivative
|
|
|
1992
|
17 |
S1 |
p. 105-
1 p.
|
artikel
|
| 112 |
Interaction of the carbocyclic analog of 2′-deoxyguanosine (CdG) with herpes simplex virus type I (HSV) thymidine kinase (TK)
|
|
|
1992
|
17 |
S1 |
p. 105-
1 p.
|
artikel
|
| 113 |
Interferon alfa-2b therapy for chinese patients with acute post transfusion hepatitis C
|
|
|
1992
|
17 |
S1 |
p. 148-
1 p.
|
artikel
|
| 114 |
Interferon-inducing activity of curantyl in volunteers
|
|
|
1992
|
17 |
S1 |
p. 157-
1 p.
|
artikel
|
| 115 |
Intracellular transport of HIV-I matrix protein pI7 as a target for aids chemotherapy
|
|
|
1992
|
17 |
S1 |
p. 74-
1 p.
|
artikel
|
| 116 |
Introduction to sponsors
|
|
|
1992
|
17 |
S1 |
p. 4-
1 p.
|
artikel
|
| 117 |
Investigation on IRS-19 (sarbach, france) in influenza A virus infection in mice and humans
|
|
|
1992
|
17 |
S1 |
p. 142-
1 p.
|
artikel
|
| 118 |
In vitro efficacy of ganciclovir alone or in combination with zidovudine against human cytomegalovirus
|
|
|
1992
|
17 |
S1 |
p. 96-
1 p.
|
artikel
|
| 119 |
In vitro evaluation of novel azolylalkoxy heterocycles as potential anti-picornavirus agents
|
|
|
1992
|
17 |
S1 |
p. 135-
1 p.
|
artikel
|
| 120 |
In vitro selection of human immunodeficiency virus type 1 resistant to 3′-Azido-3′deoxythymidine
|
|
|
1992
|
17 |
S1 |
p. 68-
1 p.
|
artikel
|
| 121 |
Lock of efficacy of a topical human leukocyte interferon-nonoxynol-9 preparation in the treatment of recurrent genital herpes
|
|
|
1992
|
17 |
S1 |
p. 126-
1 p.
|
artikel
|
| 122 |
Loss of synergy in AZT-resistant primary isolates of HIV
|
|
|
1992
|
17 |
S1 |
p. 69-
1 p.
|
artikel
|
| 123 |
LY217896: Studies on the mechanism of antiviral activity
|
|
|
1992
|
17 |
S1 |
p. 138-
1 p.
|
artikel
|
| 124 |
Measurement of association and dissociation rate constants of HIV protease inhibitors using stopped-flow fluorescence
|
|
|
1992
|
17 |
S1 |
p. 64-
1 p.
|
artikel
|
| 125 |
Mechanism of action of antiviral agents targeted against duck hepatitis B virus supercoiled DNA
|
|
|
1992
|
17 |
S1 |
p. 129-
1 p.
|
artikel
|
| 126 |
Mechanism of inhibitory effect of polyanionic polymers on human cytomegalovirus infectivity
|
|
|
1992
|
17 |
S1 |
p. 103-
1 p.
|
artikel
|
| 127 |
Mechanisms of inhibition of HIV-1 infectivity by anionic liposomes
|
|
|
1992
|
17 |
S1 |
p. 97-
1 p.
|
artikel
|
| 128 |
Metabolic disposition of BW 256U87, the l-valyl ester of acyclovir, in the rat
|
|
|
1992
|
17 |
S1 |
p. 118-
1 p.
|
artikel
|
| 129 |
Metabolism and pharmacokinetics of the acyclovir prodrug BW 256U87 in cynomolgus monkeys
|
|
|
1992
|
17 |
S1 |
p. 53-
1 p.
|
artikel
|
| 130 |
Metabolism of carbovir in CEM cells
|
|
|
1992
|
17 |
S1 |
p. 68-
1 p.
|
artikel
|
| 131 |
Mode of action of SP-303 against respiratory syncytial virus (RSV)
|
|
|
1992
|
17 |
S1 |
p. 138-
1 p.
|
artikel
|
| 132 |
Modulatory effect of N-Acetyl-Cysteine (NAC) on HIV-1 multiplication in chronically and acutely infected lymphocytes
|
|
|
1992
|
17 |
S1 |
p. 63-
1 p.
|
artikel
|
| 133 |
Molecular effects of papaverine on human cytomegalovirus replication
|
|
|
1992
|
17 |
S1 |
p. 106-
1 p.
|
artikel
|
| 134 |
MSL-109 and DHPG single and combination therapy during HCMV-induced chorioretinitis in the rabbit
|
|
|
1992
|
17 |
S1 |
p. 125-
1 p.
|
artikel
|
| 135 |
Mutant varicella-zoster virus thymidine kinase: Clinical resistance correlates with enzyme impairment
|
|
|
1992
|
17 |
S1 |
p. 103-
1 p.
|
artikel
|
| 136 |
N-3 derivatives of azido- or fluoro-dideoxythymidine: Synthesis and biological activies
|
|
|
1992
|
17 |
S1 |
p. 56-
1 p.
|
artikel
|
| 137 |
Neurologic sequelae of experimental neonatal HSV 2 infection
|
|
|
1992
|
17 |
S1 |
p. 124-
1 p.
|
artikel
|
| 138 |
New approaches for synthesizing antiviral nucleosides
|
|
|
1992
|
17 |
S1 |
p. 43-
1 p.
|
artikel
|
| 139 |
New non-invasive diagnostic method for herpes simplex virus encephalitis (HSVE) by chemiluminescent study
|
|
|
1992
|
17 |
S1 |
p. 119-
1 p.
|
artikel
|
| 140 |
New potential anti-HIV prodrugs in the D4T series
|
|
|
1992
|
17 |
S1 |
p. 61-
1 p.
|
artikel
|
| 141 |
Non-nucleoside inhibitors of an early stage of HIV reproduction
|
|
|
1992
|
17 |
S1 |
p. 73-
1 p.
|
artikel
|
| 142 |
Novel generation of heteroarylthio, sulfoxy, or sulfonyl alkyl azoles as antipicornavirus agents
|
|
|
1992
|
17 |
S1 |
p. 135-
1 p.
|
artikel
|
| 143 |
Novel polyanionic albumin derivatives are potent and selective in vitro inhibitors of HIV, FIV and SIV cell fusion and giant cell formation
|
|
|
1992
|
17 |
S1 |
p. 66-
1 p.
|
artikel
|
| 144 |
Novel synthetic Approaches to Acyclic phosphonate analogues of nucleotides. structure-activity studies
|
|
|
1992
|
17 |
S1 |
p. 128-
1 p.
|
artikel
|
| 145 |
Nucleotide analogue-9(4-hydrophosphoryl-2-oxabutyl)-guanine; ribavirine (ICN) and tromantadine (viru-mertz) as effective inhibitors TK− and PAAR strains of the HSV-1 in vitro
|
|
|
1992
|
17 |
S1 |
p. 107-
1 p.
|
artikel
|
| 146 |
On a chemotherapeutic approach using neutral anti-HIV nucleoside 5′-phosphates as potential prodrugs of their parent nucleotides
|
|
|
1992
|
17 |
S1 |
p. 84-
1 p.
|
artikel
|
| 147 |
On Antiviral properties of some drugs and possible role of viruses in formation of cardiovascular deseases
|
|
|
1992
|
17 |
S1 |
p. 155-
1 p.
|
artikel
|
| 148 |
Open study of ribavirin treatment in patients with HIV infection in stage III and IV
|
|
|
1992
|
17 |
S1 |
p. 79-
1 p.
|
artikel
|
| 149 |
Optically active isodideoxynucleosides: A new family of potential anti-HIV agents
|
|
|
1992
|
17 |
S1 |
p. 44-
1 p.
|
artikel
|
| 150 |
Oral ribavirin for the prevention of recurrences in genital herpes
|
|
|
1992
|
17 |
S1 |
p. 120-
1 p.
|
artikel
|
| 151 |
Patterns of susceptibility to acyclovir and foscarnet in 209 herpes simplex virus (HSV) isolates
|
|
|
1992
|
17 |
S1 |
p. 51-
1 p.
|
artikel
|
| 152 |
Pharmacokinetics of 1-(β-D-arabinofuranosyl)-5(E)-(2-[125 I]-iodovinyl)uracil , ([125I] IVaraU), following intravenous and subconjunctival injection in New Zealand White (NZW), rabbits
|
|
|
1992
|
17 |
S1 |
p. 119-
1 p.
|
artikel
|
| 153 |
Phenotype of ganciclovir-resistant mutants of murine cytomegalovirus
|
|
|
1992
|
17 |
S1 |
p. 116-
1 p.
|
artikel
|
| 154 |
Phosphorylation of herpes simplex virus (HSV) thymidine kinase (TK)-specific nucleosides: Effects of protein-binding, exogenous thymidine (dT), and the de novo pathway (dnp)
|
|
|
1992
|
17 |
S1 |
p. 52-
1 p.
|
artikel
|
| 155 |
Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L-1210 cells
|
|
|
1992
|
17 |
S1 |
p. 156-
1 p.
|
artikel
|
| 156 |
Plasma and cerebrospinal fluid (CSF) pharmacokinetics of dideoxy-purine nucleosides in rhesus monkeys
|
|
|
1992
|
17 |
S1 |
p. 79-
1 p.
|
artikel
|
| 157 |
Poly r(A) reverse transcriptase (3H) SPA,a new enzyme assay system
|
|
|
1992
|
17 |
S1 |
p. 48-
1 p.
|
artikel
|
| 158 |
Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating
|
|
|
1992
|
17 |
S1 |
p. 45-
1 p.
|
artikel
|
| 159 |
Potent therapeutic and prophylactic efficacy of F-PAB in mice infected with human enteroviruses
|
|
|
1992
|
17 |
S1 |
p. 142-
1 p.
|
artikel
|
| 160 |
Preclinical development of biological response modifiers intended for use in the treatment of HIV infection and associated disorders
|
|
|
1992
|
17 |
S1 |
p. 75-
1 p.
|
artikel
|
| 161 |
Preliminary characterization of HSV-1 protease by expression in E. coli
|
|
|
1992
|
17 |
S1 |
p. 50-
1 p.
|
artikel
|
| 162 |
Prevention of cytomegalovirus (CMV) disease after allogeneic marrow transplant by ganciclovir prophylaxis
|
|
|
1992
|
17 |
S1 |
p. 127-
1 p.
|
artikel
|
| 163 |
Prophylactic efficacy of WIN 54954 in prevention of experimental human coxsackievirus A21 infection and illness
|
|
|
1992
|
17 |
S1 |
p. 92-
1 p.
|
artikel
|
| 164 |
Protective immune responses in animals vaccinated with the FHN subunit vaccine for control of human parainfluenza-3 virus
|
|
|
1992
|
17 |
S1 |
p. 141-
1 p.
|
artikel
|
| 165 |
Quantification of viral nucleic acids
|
|
|
1992
|
17 |
S1 |
p. 127-
1 p.
|
artikel
|
| 166 |
Quantitation of acyclic adenine nucleoside phosphonate concentrations in human plasma using high-performance liquid chromatography and fluorescence detection
|
|
|
1992
|
17 |
S1 |
p. 156-
1 p.
|
artikel
|
| 167 |
Quinobene, a new synthetic sulfonated dye with potent anti-HIV activity
|
|
|
1992
|
17 |
S1 |
p. 73-
1 p.
|
artikel
|
| 168 |
Rapid, convenient, synthesis of γ-emitting, no-carrier-added (NCA) 1-(ß-D-arabinofuranosyl)-5(E)-(2-radiohalogenovinyl)uracil probes for the detection of herpes simplex virus (HSV)-specified thymidine kinase in vitro and in vivo
|
|
|
1992
|
17 |
S1 |
p. 95-
1 p.
|
artikel
|
| 169 |
Rapid emergence of HIV-1 resistant to non-nucleoside inhibitors of reverse transcriptase
|
|
|
1992
|
17 |
S1 |
p. 48-
1 p.
|
artikel
|
| 170 |
Reduction of respiratory syncytial virus (RSV) shedding in African green monkeys treated with SP303
|
|
|
1992
|
17 |
S1 |
p. 91-
1 p.
|
artikel
|
| 171 |
Regions of HIV reverse transcriptase involved in resistance to several nonnucleoside inhibitors
|
|
|
1992
|
17 |
S1 |
p. 70-
1 p.
|
artikel
|
| 172 |
Resistance of sindbis virus to some adamantine compounds
|
|
|
1992
|
17 |
S1 |
p. 151-
1 p.
|
artikel
|
| 173 |
Retroviral vectors expressing antisense and ribozyme rna directed against HIV-1 TAT can inhibit HIV-1 replication
|
|
|
1992
|
17 |
S1 |
p. 75-
1 p.
|
artikel
|
| 174 |
Reversal of established FeLV-FAIDS infection after adoptive transfer of activated lymphocytes in combination with AZT and alpha interferon NS zeidner 1
|
|
|
1992
|
17 |
S1 |
p. 86-
1 p.
|
artikel
|
| 175 |
Ribavirin therapy for chinese patients with chronic hepatitis C
|
|
|
1992
|
17 |
S1 |
p. 147-
1 p.
|
artikel
|
| 176 |
Role of NK cells and interferon in immunomodulator/biological response modifier (BRM)-mediated resistance against HSV-2 and MCMV infection in immunosuppressed
|
|
|
1992
|
17 |
S1 |
p. 110-
1 p.
|
artikel
|
| 177 |
Scientific program
|
|
|
1992
|
17 |
S1 |
p. 6-42
37 p.
|
artikel
|
| 178 |
SDZ-HSV-863: A human monoclonal antibody to HSV-1 and HSV-2 (gD-Ib) which attenuates acute infection, neurogenic cutaneous lesion formation and the establishment of viral latency
|
|
|
1992
|
17 |
S1 |
p. 52-
1 p.
|
artikel
|
| 179 |
Search for antiviral compounds against influenza and some other viruses causing respiratory deseases
|
|
|
1992
|
17 |
S1 |
p. 136-
1 p.
|
artikel
|
| 180 |
Selection of the acetal 2-amino-9-[3-(isopropoxymethoxy)propoxy]purine (BRL 55792) as an oral prodrug of the anti-herpesvirus agent 9-(3-hydroxypropoxy)guanine (BRL 44385)
|
|
|
1992
|
17 |
S1 |
p. 117-
1 p.
|
artikel
|
| 181 |
Selective anti - human rhinovirus activity of disoxaril analogues
|
|
|
1992
|
17 |
S1 |
p. 90-
1 p.
|
artikel
|
| 182 |
Selective inhibition of moloney murine leukemia virus cycle at the integration step by the netropsine-intercalating hybrid molecule Net-OPC
|
|
|
1992
|
17 |
S1 |
p. 83-
1 p.
|
artikel
|
| 183 |
Selenoorganic compounds useful as anti-HIV inhibitors
|
|
|
1992
|
17 |
S1 |
p. 60-
1 p.
|
artikel
|
| 184 |
Sequence variations in the reverse transcriptase of HIV-1 from AZT-treated patients map to the binding site of a postulated HIV-1 RT model
|
|
|
1992
|
17 |
S1 |
p. 72-
1 p.
|
artikel
|
| 185 |
Sequential varicella zoster virus isolates from an AIDS patient: Phenotypic and genetic evidence for evolution of drug resistance at the thymidine kinase and DNA polymerase loci
|
|
|
1992
|
17 |
S1 |
p. 51-
1 p.
|
artikel
|
| 186 |
Single-dose pharmacokinetics of nevirapine (BI-RG-587)
|
|
|
1992
|
17 |
S1 |
p. 157-
1 p.
|
artikel
|
| 187 |
Social functions
|
|
|
1992
|
17 |
S1 |
p. 5-
1 p.
|
artikel
|
| 188 |
Some correlations between rimantadine-sensitive and rimantadine resistant influenza virus clones in the general populations of drug-sensitive viruses
|
|
|
1992
|
17 |
S1 |
p. 139-
1 p.
|
artikel
|
| 189 |
Spontaneous reactivation of thymidine kinase deficient (TK−) herpes simplex virus (HSV) infection without acyclovir (ACV) pressure in a patient with the acquired immunodeficiency syndrome (AIDS)
|
|
|
1992
|
17 |
S1 |
p. 104-
1 p.
|
artikel
|
| 190 |
Structure-activity relationships of new inhibitors of S-adenosylmethionine decarboxylase and their effect on the replication of human cytomegalovirus
|
|
|
1992
|
17 |
S1 |
p. 102-
1 p.
|
artikel
|
| 191 |
Suppression of human papillomavirus type 16 E7 expression in human keratinocytes by alpha interferons
|
|
|
1992
|
17 |
S1 |
p. 93-
1 p.
|
artikel
|
| 192 |
Suppression of murine retroviral disease as a model for AIDS by 2′,3′-dideoxy-2′,3′-didehydrothymidine (D4T)
|
|
|
1992
|
17 |
S1 |
p. 132-
1 p.
|
artikel
|
| 193 |
Syntheses of a series of 6-substituted pyrimidines including orotidylic acid decarboxylase inhibitors, and in vitro evaluation of their antiviral efficacy
|
|
|
1992
|
17 |
S1 |
p. 150-
1 p.
|
artikel
|
| 194 |
Synthesis and anti-HIV activity of 2-substituted, 6-benzyl-pyrimidine derivatives
|
|
|
1992
|
17 |
S1 |
p. 62-
1 p.
|
artikel
|
| 195 |
Synthesis and anti-HIV and anti-HBV activity of enantiomerically pure oxathiolane nucleosides
|
|
|
1992
|
17 |
S1 |
p. 44-
1 p.
|
artikel
|
| 196 |
Synthesis and anti-HSV-1 activity of 5-substituted 2′-deoxyuridines
|
|
|
1992
|
17 |
S1 |
p. 58-
1 p.
|
artikel
|
| 197 |
Synthesis and antiviral activity of novel 5-ethyl- and 5-vinyl-2′-deoxyuridine analogues
|
|
|
1992
|
17 |
S1 |
p. 50-
1 p.
|
artikel
|
| 198 |
Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives
|
|
|
1992
|
17 |
S1 |
p. 94-
1 p.
|
artikel
|
| 199 |
Synthesis and antiviral evaluation of 1-deaza-8-aza and 3-deaza-8-aza-purine nucleosides
|
|
|
1992
|
17 |
S1 |
p. 154-
1 p.
|
artikel
|
| 200 |
Synthesis and antiviral properties of carbocycllc 3′-Oxa-2′,3′-dideoxyguanosine
|
|
|
1992
|
17 |
S1 |
p. 54-
1 p.
|
artikel
|
| 201 |
Synthesis and HIV-1 reverse transcriptase inhibition of 3′-azido-3′,5′-dideoxythymidine 5′-methylphosphonic acid diphosphate
|
|
|
1992
|
17 |
S1 |
p. 65-
1 p.
|
artikel
|
| 202 |
Synthesis and in vitro anti-HIV activity of 2′,3′-dideoxy-2′,3′-methanonucleosides and of 3′-deoxy-2′,3′-(difluoromethano)thymidine
|
|
|
1992
|
17 |
S1 |
p. 55-
1 p.
|
artikel
|
| 203 |
Synthesis and in vivo anti-RNA-viral evaluation of a phosphoramidate derivative of 6-Azauridine; orotidylic acid decarboxylase inhibitors, pyrazofurin and 6-azauridine; and 2-Thio-6-azauridine and its triacetate
|
|
|
1992
|
17 |
S1 |
p. 149-
1 p.
|
artikel
|
| 204 |
Synthesis and properties of 8-benzyl-4-dimethylaminoimidazo [1,5-α]-1,3,5-triazines , isosters of antirhinoviral purines
|
|
|
1992
|
17 |
S1 |
p. 134-
1 p.
|
artikel
|
| 205 |
Synthesis and structure-activity relationships in a novel class of polyamines that inhibit HIV-1 and HIV-2 replication
|
|
|
1992
|
17 |
S1 |
p. 55-
1 p.
|
artikel
|
| 206 |
Synthesis, anti-HIV activity and cytotoxicity of derivatives of 5-hydroxymethyl-deoxyuridine
|
|
|
1992
|
17 |
S1 |
p. 56-
1 p.
|
artikel
|
| 207 |
Systemic application of the interferon inducer (ds RNA) for the treatment of HSV-infection
|
|
|
1992
|
17 |
S1 |
p. 121-
1 p.
|
artikel
|
| 208 |
The clinical investigation of the combined treatment of PolyI:C and thymosine on patients with chronic hepatitis B
|
|
|
1992
|
17 |
S1 |
p. 148-
1 p.
|
artikel
|
| 209 |
The effect of glycosylation inhibitors on the replication of junin virus
|
|
|
1992
|
17 |
S1 |
p. 150-
1 p.
|
artikel
|
| 210 |
The enzymatic synthesis of antiviral nucleosides
|
|
|
1992
|
17 |
S1 |
p. 58-
1 p.
|
artikel
|
| 211 |
The SCID mouse model for evaluation of antiviral agents against murine cytomegalovirus (MCMV)
|
|
|
1992
|
17 |
S1 |
p. 124-
1 p.
|
artikel
|
| 212 |
The successful treatment of calves experimentally infected with bovine rhinotracheitis virus (BHV-1) by means of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) during acute and reactivated infections
|
|
|
1992
|
17 |
S1 |
p. 125-
1 p.
|
artikel
|
| 213 |
The synthesis and evaluation of hypericin and analogs of hypericin
|
|
|
1992
|
17 |
S1 |
p. 57-
1 p.
|
artikel
|
| 214 |
The virologic effect of high dose recombinant soluble CD4 (rsCD4) in HIV+ individuals
|
|
|
1992
|
17 |
S1 |
p. 133-
1 p.
|
artikel
|
| 215 |
Three-dimensional structure of a ternary complex of human immunodeficiency virus-1 reverse transcriptase, a monoclonal antibody Fab fragment, and double-stranded DNA
|
|
|
1992
|
17 |
S1 |
p. 82-
1 p.
|
artikel
|
| 216 |
Treatment of anogenital warts with recombinant interferon gamma: Results of two multicenter placebo-controlled clinical trials
|
|
|
1992
|
17 |
S1 |
p. 149-
1 p.
|
artikel
|
| 217 |
Treatment of chronic fatigue syndrome (CFS) with ampligen®
|
|
|
1992
|
17 |
S1 |
p. 159-
1 p.
|
artikel
|
| 218 |
Treatment of genital herpes simplex virus infections of mice and guinea pigs with famciclovir, an oral prodrug of penciclovir
|
|
|
1992
|
17 |
S1 |
p. 113-
1 p.
|
artikel
|
| 219 |
Treatment of herpes simplex virus type 2 infections in mice with murine and humanized monoclonal antibodies (MABS)
|
|
|
1992
|
17 |
S1 |
p. 109-
1 p.
|
artikel
|
| 220 |
Treatment of respiratory-syncytial viral infection in children of early ages with ribovirin in aerosol
|
|
|
1992
|
17 |
S1 |
p. 143-
1 p.
|
artikel
|
| 221 |
Use of a filter binding sample preparation method for the PCR detection of hepatitis B virus (HBV) in cell culture or in human sera and for the demonstration of the anti-HBV activity of two halogenated pyrimidine nucleoside analogs
|
|
|
1992
|
17 |
S1 |
p. 145-
1 p.
|
artikel
|
| 222 |
Use of stepwise linear regression combined with analysis of covariance to analyze drug combination interactions
|
|
|
1992
|
17 |
S1 |
p. 96-
1 p.
|
artikel
|
| 223 |
Virological identification of three subgroups of patients during extended treatment with zidovudine
|
|
|
1992
|
17 |
S1 |
p. 81-
1 p.
|
artikel
|
| 224 |
Virological identification of three subgroups of patients during extended treatment with zidovudine
|
|
|
1992
|
17 |
S1 |
p. 132-
1 p.
|
artikel
|
Tijdschrift beschrijving